Melbourne, Dec 21, 2009 (ABN Newswire) - Australian regenerative medicine company, Mesoblast Limited ( ASX:MSB)( PINK:MBLTY), today confirmed that national news items broadcast last Friday on the ABC, Channel 9, Channel 7 and Channel 10 reported on positive preclinical results using its patented adult stem cell technology platform for the treatment of diabetes.
